Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

enoxaparin

enoxaparin is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 7
News articles 0
Drug details — enoxaparin
Class
—
Route
—
Patents
2
Programs
7
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

enoxaparin is an FDA-listed pharmaceutical active ingredient.

Key facts

INN enoxaparin

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. DSC/08/2357/32 Phase 3 · ITALFARMACO S.P.A · JAK2V617F-positive high-risk Polycythemia Vera
  2. ENOXAPARIN Phase 3 · PARItec · Allograft vascular thrombosis
  3. Enoxaparin Phase 3 · Bristol Myers Squibb · Deep Vein Thrombosis
  4. Enoxaparin sodium (XRP4563) Phase 3 · Sanofi Pasteur MSD · Myocardial Infarction
  5. Enoxaparin Phase 2 · Chinese Academy of · Pregnancy Related
  6. Enoxaparin Approved · Sanofi Pasteur MSD · Acute Illness
  7. Enoxaparin 40 mg q12h Approved · United Therapeutics Europe · Traumatic Injury

Related patents

Browse patents

  1. US 2010331746

    METHOD OF USING ENOXAPARIN FOR REDUCING THE RISK OF DEATH IN ACUTELY ILL MEDICAL PATIENTS

    Expires Wed Dec 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. AU 2009200642

    Method using enoxaparin for reducing the risk of death in acutely ill medical patients

    Expires Wed Sep 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is enoxaparin?

enoxaparin is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.